Literature DB >> 3664931

The anti-oestrogen tamoxifen is a calcium antagonist in perfused rat mesentery.

A Lipton1.   

Abstract

The anti-oestrogen tamoxifen in the range 10(-7)-10(-5) M induced concentration-related inhibition of potassium-stimulated vasospasm in the isolated perfused rat mesentery vascular bed. In contrast, responses to noradrenaline did not fall below control levels until the tamoxifen concentration exceeded 4 X 10(-6) M. Recovery of the potassium-stimulated responses was also concentration-related. The most likely explanation is that while tamoxifen can obstruct the entry of extracellular calcium, it is unable to prevent the intracellular release of the ion by noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664931     DOI: 10.1007/bf00253965

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

Review 1.  Cell membrane ionic permeability, calcium ion, mitochondria, and carcinogenesis.

Authors:  L J Anghileri
Journal:  Arch Geschwulstforsch       Date:  1978

2.  Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor.

Authors:  H Rochefort; M Garcia; J L Borgna
Journal:  Biochem Biophys Res Commun       Date:  1979-05-28       Impact factor: 3.575

Review 3.  The pharmacology and clinical uses of tamoxifen.

Authors:  B J Furr; V C Jordan
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

4.  Tamoxifen and hypercalcemia.

Authors:  J S Patterson; B J Furr; L A Battersby
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

5.  Mobilization of extracellularly bound Ca2+ during high K+ and norepinephrine stimulation of the rabbit aorta.

Authors:  N J Lodge; C van Breemen
Journal:  Blood Vessels       Date:  1985

6.  Tamoxifen and hypercalcemia.

Authors:  S D Lane; E C Besa; R R Joseph
Journal:  Ann Intern Med       Date:  1980-04       Impact factor: 25.391

7.  Evidence for two separated Ca2+ pathways in smooth muscle plasmalemma.

Authors:  K D Meisheri; O Hwang; C van Breemen
Journal:  J Membr Biol       Date:  1981-03-15       Impact factor: 1.843

8.  Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.

Authors:  H Y Lam
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

9.  Acute inhibition of rat myometrial responses to oxytocin by tamoxifen stereoisomers and oestradiol.

Authors:  A Lipton; A Vinijsanun; L Martin
Journal:  J Endocrinol       Date:  1984-12       Impact factor: 4.286

10.  Calcium antagonism by the antioestrogen tamoxifen.

Authors:  A Lipton; I D Morris
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more
  1 in total

1.  Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes.

Authors:  S Batra
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.